Department of Urologic Oncology, Masaryk Memorial Cancer Institute, Brno; Department of Surgical Oncology, Faculty of Medicine, Masaryk University, Brno.
Research Group Bioinformatics, Masaryk Memorial Cancer Institute, Brno.
Urology. 2024 Oct;192:126-132. doi: 10.1016/j.urology.2024.05.034. Epub 2024 Jun 1.
To present long-term experience with buccal mucosa posterior urethroplasty (BMPU) for refractory posterior urethral stenosis (PUS) or vesicourethral anastomosis stenosis (VUAS) either by perineal approach (PA) or by endourethroplasty (EUP).
A single-center retrospective study of 38 consecutive patients operated on between 1999 and 2022. BMPU consisted of the transfer of onlay or tubular buccal mucosa grafts into dilated and/or incised strictures through an open or endourological approach. If VUAS or PUS recurred with short stenosis within the first 12 months after surgery, it was transected by a cold-knife direct vision internal urethrotomy (DVIU), referred to as an "auxiliary" DVIU. The primary outcome was 3-year stricture recurrence-free survival (SRFS).
BMPU by perineal approach and EUP were performed in 27 (71%) and 11 (29%) patients, respectively. The 3-year SRFS was 65% for the whole cohort, with rates of 63% for the perineal approach and 73% for endourological approach. With permitted auxiliary DVIU, 3-year SRFS for the whole cohort was 81%. De novo incontinence occurred in 2 out of 18 preoperatively continent patients. Limitations include the retrospective nature of the single-center study and a small, heterogenous cohort of patients.
We present 2 techniques of substitution urethroplasty with BMG in the management of PUS and VUAS with a low rate of recurrence or de novo incontinence. A novel endourological approach (EUP) is a promising minimally invasive alternative to the perineal approach.
介绍通过会阴入路(PA)或腔内尿道成形术(EUP)行颊黏膜后尿道成形术(BMPU)治疗难治性后尿道狭窄(PUS)或吻合口后尿道狭窄(VUAS)的长期经验。
这是一项单中心回顾性研究,纳入了 1999 年至 2022 年间连续 38 例接受手术的患者。BMPU 包括通过开放或腔内途径将颊黏膜游离皮瓣或管状移植物转移到扩张和/或切开的狭窄部位。如果术后 12 个月内出现短段狭窄的 VUAS 或 PUS 复发,通过冷刀直视尿道内切开术(DVIU)进行再次切开,称为“辅助”DVIU。主要结局是 3 年无狭窄复发生存率(SRFS)。
PA 和 EUP 行 BMPU 的患者分别为 27(71%)和 11(29%)例。全组患者的 3 年 SRFS 为 65%,PA 组为 63%,EUP 组为 73%。允许行辅助 DVIU 时,全组患者的 3 年 SRFS 为 81%。18 例术前控尿的患者中有 2 例发生新发尿失禁。本研究的局限性包括单中心研究的回顾性和患者的数量较少、异质性较大。
我们介绍了两种使用 BMG 进行替代尿道成形术的技术,用于治疗 PUS 和 VUAS,其复发率或新发尿失禁率较低。一种新的腔内尿道成形术(EUP)是一种有前途的微创替代会阴入路的方法。